Postoperative Anemia After Bariatric Surgery

NCT06198790 · tracked via the Priya Life Science China tracker

Sponsor

China-Japan Friendship Hospital

Phase

Observational

Started

2024-02-01

Last updated

2025-08-03

Condition(s) studied

AnemiaBariatric Surgery Candidate

Study summary

To investigate the real incidence of short and long-term anemia after bariatric surgery, and explore the risk factors.

Eligibility

Sex

ALL

Min age

16 Years

Max age

70 Years

Healthy volunteers

Inclusion Criteria: * Patients who will undergo sleeve gastrectomy or Roux-en-Y gastric bypass * Aged between 16 and 70 years * Patients who is not diagnosed as anemia at baseline Exclusion Criteria: * Patients who have anemia at baseline

Primary outcome measure(s)

Incidence of anemia after 1, 3, 5, 10 years — 10 years
Incidence of anemia after 1, 3, 5, 10 years

Trial sites (1)

Facility	City	Region	Status
Yuntao Nie	Beijing	China	Recruiting

More China-Japan Friendship Hospital trials in China

PCT Guided Antibiotics Use in Critically Ill Adult Patients in China Starting soon

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS) Recruiting

A Prediction Model of Prolonged Mechanical Ventilation Following Acute Type A Aortic Dissection Surgery Starting soon

A Single-center, Prospective Study for Mechanism and Risk Factors of Tracheal Tube-related Tongue Injury Active, not recruiting

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis Recruiting

Other trials for the same condition

Effectiveness of Bariatric Surgery for NAFLD/NASH Recruiting

Wearable Device-Based Screening for Anemia Risk Starting soon

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia Active, not recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06198790 on ClinicalTrials.gov ↗ ← All trials in China